Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rebixiao Chinese Formula Granules
- Development stage
- Preclinical
- Lead developer
- Chongqing City Hospital of Traditional Chinese Medicine
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Rebixiao Chinese Formula Granules (also known as Rebixiao granules) is a traditional Chinese medicine (TCM) herbal formulation developed by the Chongqing Hospital of Traditional Chinese Medicine for the treatment of gout and acute gouty arthritis. The formula typically consists of herbal ingredients such as Hypoglauca yam (萆薢), giant knotweed rhizome (虎杖), Phellodendron bark (黄柏), and Smilax glabra rhizome (土茯苓), which work synergistically to clear heat, resolve dampness, and alleviate joint pain and swelling. Rebixiao has been evaluated in clinical trials, including randomized controlled trials and observational studies, demonstrating efficacy in reducing joint symptoms, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) levels in patients with acute gouty arthritis, with a favorable safety profile.
- Other names
- RBX CFGRBXGRe-Bi-Xiao granulesRebixiaoRebixiao granules
Beyond the preview
Go deeper on Rebixiao Chinese Formula Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rebixiao Chinese Formula Granules.